The Nguyen Report

King Resources unwinds a major collectibles acquisition, canceling over 62 million shares after items failed to sell, raising questions about market risks.

A groundbreaking trial testing if a coffee infused with an ancient herb can slow prostate cancer recurrence is nearing completion, offering hope for a new era.

The relentless pursuit of a perfect sleep score may be the very thing ruining your rest. Experts warn of a new phenomenon called 'orthosomnia'.

A new partnership brings advanced AI and customer information systems to Canada's utility sector, promising a new era of digital transformation.

AMBA's acquisition of Amwins' affinity and BPO units aims to create an end-to-end powerhouse, reshaping the competitive landscape for member benefits.

With a $60M war chest, Gyde acquires a top Medicare agency to deploy its AI platform, aiming to blend high-tech efficiency with a human touch.

With a new patent for its drug ALPHA-1062, Alpha Cognition may become a first-mover in the $14 billion traumatic brain injury market, which has no approved therapies.

The new pre-configured kits aim to reduce patient confusion and improve outcomes, tapping into the growing multi-billion dollar home healthcare market.

As downtime costs soar and new EU regulations demand rapid recovery, a new solution offers instant continuity by bridging Microsoft 365 and Google Workspace.

With FDA approval for a pivotal trial, VDYNE advances its unique valve replacement system, offering new hope for millions with severe tricuspid regurgitation.

3WIN's purchase of a patented filling machine maker signals a major shift towards vertical integration and efficiency in the booming global cannabis market.

A landmark case could strip healthcare giants of a key legal defense, holding them accountable for allegedly deceiving seniors into for-profit Medicare plans.

The biopharma firm touts transformative drug data ahead, but with cash for only month-to-month operations, its future hangs by a precarious thread.

The energy services firm reports a 90% jump in adjusted EBITDA, crediting disciplined spending and a lucrative foray into the Alaskan snubbing market.

The carbon-tech firm slashes losses and touts a key SAF partnership, but dwindling cash reserves raise questions about its path to sustainable growth.

Glenmark Pharmaceuticals challenges established brands with its new GLN-Minoxidil 5% foam, aiming to make hair regrowth treatment more accessible and convenient.

A new tech partnership aims to slash wait times and red tape, connecting millions of employees directly to therapists' calendars through a new 'digital front door'.

With $8M from top VCs, this AI startup built by ex-agents is automating 70% of an agent's day, aiming to revolutionize the insurance industry.

In Las Vegas, Ziebart celebrated record franchise growth and new tech, proving its strength lies in a dual strategy of innovation and a people-first culture.

As teens grow up on algorithms, one expert says schools are failing them. She proposes a radical shift: using tech as a tool, not a distraction.